Theras

Theras is an Italian biomedical company founded in 2011 that develops and promotes advanced technologies and services for the therapeutic management of chronic diseases, alongside the distribution of medical devices and consumer health products. Its technical areas include continuous glucose monitoring, insulin pump therapy and automated insulin delivery, neuromodulation for chronic pain, and weight management and obesity therapies. The company is headquartered in Salsomaggiore Terme, Parma, and works with hospitals and specialist clinics across Italy.

The company holds exclusive Italian distribution rights for several international medical device brands. These include Dexcom continuous glucose monitoring systems, Insulet's Omnipod tubeless insulin pump system, and Nevro's chronic pain therapies. It also distributes Plenity, a weight management product, and maintains Pic Solution, a consumer health brand acquired by the group. Theras operates through three divisions: Theras Lifetech, Theras Consumer Health, and Theras Biocare.

Theras employs approximately 80 people. Revenue rose from EUR 32m in 2018 to nearly EUR 65m in 2019, a 100% increase in one year, and the company is connected to over 100 hospitals and specialist clinics throughout Italy. The Financial Times has listed it among Europe's fastest-growing companies, and it has received awards for business excellence and financial reliability.